Compare ROIV & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | EXPD |
|---|---|---|
| Founded | 2014 | 1979 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2B | 21.0B |
| IPO Year | 2021 | 1995 |
| Metric | ROIV | EXPD |
|---|---|---|
| Price | $34.80 | $167.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 11 |
| Target Price | $28.94 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 5.8M | 1.3M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | N/A | ★ 4.02 |
| EPS | N/A | ★ 1.71 |
| Revenue | $8,260,000.00 | ★ $6,920,948,000.00 |
| Revenue This Year | N/A | $2.71 |
| Revenue Next Year | $744.61 | $3.74 |
| P/E Ratio | ★ N/A | $97.92 |
| Revenue Growth | N/A | ★ 13.49 |
| 52 Week Low | $10.71 | $110.48 |
| 52 Week High | $35.90 | $168.52 |
| Indicator | ROIV | EXPD |
|---|---|---|
| Relative Strength Index (RSI) | 71.26 | 63.14 |
| Support Level | $26.65 | $157.54 |
| Resistance Level | N/A | $167.86 |
| Average True Range (ATR) | 1.17 | 3.18 |
| MACD | 0.39 | 0.06 |
| Stochastic Oscillator | 82.59 | 90.06 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2025, Expeditors derived 36% of consolidated gross revenue from airfreight, 25% from ocean freight, and 39% from customs brokerage and other services.